C
Clara C. Chan
Researcher at University of Toronto
Publications - 129
Citations - 2068
Clara C. Chan is an academic researcher from University of Toronto. The author has contributed to research in topics: Medicine & Visual acuity. The author has an hindex of 19, co-authored 108 publications receiving 1306 citations. Previous affiliations of Clara C. Chan include St. Michael's Hospital & University Health Network.
Papers
More filters
Journal ArticleDOI
Global Consensus on Definition, Classification, Diagnosis, and Staging of Limbal Stem Cell Deficiency.
Sophie X. Deng,Vincent Borderie,Clara C. Chan,Reza Dana,Francisco C. Figueiredo,José Álvaro Pereira Gomes,Graziella Pellegrini,Shigeto Shimmura,Friedrich E. Kruse +8 more
TL;DR: A global consensus is reached on the definition, classification, diagnosis, and staging of LSCD, which will facilitate a better understanding of the condition and help with clinical management, research, and clinical trials in this area.
Journal ArticleDOI
Ab externo scleral suture loop fixation for posterior chamber intraocular lens decentration: clinical results.
TL;DR: The ab externo suture loop retrieval and scleral fixation technique was effective in repositioning decentered, subluxated, or dislocated PC IOLs with excellent visual outcomes.
Journal ArticleDOI
Systemic immunosuppression in ocular surface stem cell transplantation: results of a 10-year experience
Edward J. Holland,G. Mogilishetty,Heather M. Skeens,David B. Hair,Kristiana D. Neff,Joseph M. Biber,Clara C. Chan +6 more
TL;DR: With appropriate long-term monitoring by the cornea specialist and transplant physician, the risk of irreversible toxicity at current dosages of systemic immunosuppression in patients undergoing ocular surface stem cell transplantation in this population is minimal.
Journal ArticleDOI
Accelerated (9 mW/cm2) corneal collagen crosslinking for keratoconus--a 1-year follow-up.
Uri Elbaz,Carl Shen,Alejandro Lichtinger,Noa Avni Zauberman,Yakov Goldich,Clara C. Chan,Allan R. Slomovic,David S. Rootman +7 more
TL;DR: Accelerated corneal CXL is effective in stabilizing topographic parameters after 12 months of follow-up in mild-moderate keratoconus-affected corneas, and improvement in the UDVA and stabilization of all testedCorneal parameters were noted after the treatment.
Journal ArticleDOI
Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK).
TL;DR: The development of alternative preservatives, preservative-free topical options, and non-drop therapeutics such as drug-eluting systems for the delivery of ocular medications, will be very helpful in the care of glaucoma patients.